Literature DB >> 6889695

Muscle calcium and magnesium content in Duchenne muscular dystrophy.

T E Bertorini, S K Bhattacharya, G M Palmieri, C M Chesney, D Pifer, B Baker.   

Abstract

Calcium (Ca) and magnesium (Mg) content were determined in muscle of 27 patients with Duchenne muscular dystrophy, 36 with other neuromuscular diseases, and 22 whose muscle biopsy specimens were histochemically normal. Muscle Ca was significantly elevated in all diseases studied but was about 50% higher in Duchenne dystrophy patients (p less than 0.0001). Mg was decreased by 44% in Duchenne dystrophy, compared with less striking deficits in other diseases (p less than 0.005). In older, nonambulatory Duchenne dystrophy patients, Mg was significantly lower than in younger, ambulatory patients (p less than 0.001); muscle Ca was the same in both groups. On the basis of noncollagen nitrogen concentration, muscle MG depletion could not be attributed solely to reduced muscle mass. These findings strengthen arguments for a role of Ca in the pathogenesis of muscular dystrophy and may implicate Mg depletion as another pathogenetic factor.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6889695     DOI: 10.1212/wnl.32.10.1088

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  19 in total

Review 1.  New insights in the regulation of calcium transfers by muscle dystrophin-based cytoskeleton: implications in DMD.

Authors:  Bruno Constantin; Stéphane Sebille; Christian Cognard
Journal:  J Muscle Res Cell Motil       Date:  2006-08-04       Impact factor: 2.698

2.  Cellular mechanism underlying the facilitation of contractile response of vas deferens smooth muscle by sodium orthovanadate.

Authors:  Lei Zhao; Zhe Wang; Ye-Chun Ruan; Wen-Liang Zhou
Journal:  Mol Cell Biochem       Date:  2012-04-04       Impact factor: 3.396

Review 3.  Role of STIM1/ORAI1-mediated store-operated Ca2+ entry in skeletal muscle physiology and disease.

Authors:  Antonio Michelucci; Maricela García-Castañeda; Simona Boncompagni; Robert T Dirksen
Journal:  Cell Calcium       Date:  2018-10-30       Impact factor: 6.817

Review 4.  Duchenne muscular dystrophy: pathogenetic aspects and genetic prevention.

Authors:  H Moser
Journal:  Hum Genet       Date:  1984       Impact factor: 4.132

5.  Immunoblot analysis of sarcoplasmic calcium binding proteins in Duchenne muscular dystrophy.

Authors:  I Niebrój-Dobosz; M Lukasiuk
Journal:  J Neurol       Date:  1995-01       Impact factor: 4.849

6.  Duchenne muscular dystrophy and dystrophin: sequence homology observations.

Authors:  A D Gurusinghe; M C Wilce; L Austin; M T Hearn
Journal:  Neurochem Res       Date:  1991-06       Impact factor: 3.996

7.  Intracellular Ca2+ concentrations are not elevated in resting cultured muscle from Duchenne (DMD) patients and in MDX mouse muscle fibres.

Authors:  J Pressmar; H Brinkmeier; M J Seewald; T Naumann; R Rüdel
Journal:  Pflugers Arch       Date:  1994-04       Impact factor: 3.657

8.  Heterokaryon myotubes with normal mouse and Duchenne nuclei exhibit sarcolemmal dystrophin staining and efficient intracellular free calcium control.

Authors:  W F Denetclaw; G Bi; D V Pham; R A Steinhardt
Journal:  Mol Biol Cell       Date:  1993-09       Impact factor: 4.138

Review 9.  Vitamin E and muscle diseases.

Authors:  M J Jackson; D A Jones; R H Edwards
Journal:  J Inherit Metab Dis       Date:  1985       Impact factor: 4.982

10.  Genetic correction of splice site mutation in purified and enriched myoblasts isolated from mdx5cv mice.

Authors:  Katie Maguire; Takayuki Suzuki; Darlise DiMatteo; Hetal Parekh-Olmedo; Eric Kmiec
Journal:  BMC Mol Biol       Date:  2009-02-23       Impact factor: 2.946

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.